Greater improvements seen with combination for older women with overactive bladder symptoms. (HealthDay News) — For older women, behavioral therapy (BT) reduces overactive bladder (OAB) symptoms, with ...

High-dose tirzepatide is associated with superior HbA1c reduction and weight loss compared with semaglutide in type 2 diabetes and obesity.

At the time of kidney transplantation, a novel model incorporating up to 14 variables can predict the recipient’s risk of death. High-risk individuals warrant increased monitoring and tailored ...

(HealthDay News) — Advanced cardiovascular-kidney-metabolic (CKM) syndrome stage, especially stages 3 and 4, is associated with increased cancer risk, according to a study published online April 27 in ...

Biomarkers are needed in metastatic prostate cancer to stratify patient response early after initiation of systemic treatment.

Storage symptoms favored the OAB group, despite comparable overall symptom improvement for those with, without OAB.

Similar associations seen between longer treatment times with reduced hospitalization rates, shorter hospital stays.

Tirzepatide significantly improves health-related quality of life and physical functioning compared with dulaglutide in patients with T2D.

Mitomycin gel has a favorable durability of response rate at 24 months among treated trial patients with low grade, intermediate-risk non-muscle invasive bladder cancer.

Instead of protecting women from research, such as those with childbearing potential, clinical trial ethics advocate for protecting women through research. Innovation and advances in modern medical ...